Dashboard
Manage Tickers

CLDX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

celldex-releases-new-exploratory-data-from-its-phase-2-study-showing-that-barzolvolimab-improves-urticaria-control-in-patients-with-chronic-spontaneous-urticaria
Celldex Releases New Exploratory Data From...
11/06/2025 13:21:35

Celldex (NASDAQ:CLDX) announced today new data on exploratory endpoints (UCT7) further demonstrating barzolvolimab's abilit...

celldex-releases-phase-1-results-for-its-bispecific-antibody-cdx-622-showing-drug-was-well-tolerated-showed-favorable-pharmacokinetics-and-led-to-rapid-sustained-reductions-in-serum-tryptase-confirming-effective-mast-cell-inhibition
Celldex Releases Phase 1 Results For Its B...
10/30/2025 20:14:52

Celldex (NASDAQ:CLDX) announced today positive data from the ongoing Phase 1 study of CDX-622, a novel bispecific antibody that...

mizuho-initiates-coverage-on-celldex-therapeutics-with-outperform-rating-announces-price-target-of-48
Mizuho Initiates Coverage On Celldex Thera...
10/21/2025 12:44:06

Mizuho analyst Joseph Catanzaro initiates coverage on Celldex Therapeutics (NASDAQ:CLDX) with a Outperform rating and announ...

analyst-expectations-for-celldex-therapeuticss-future
Analyst Expectations For Celldex Therapeut...
10/13/2025 20:01:52

barclays-initiates-coverage-on-celldex-therapeutics-with-underweight-rating-announces-price-target-of-25
Barclays Initiates Coverage On Celldex The...
10/13/2025 12:17:38

Barclays analyst Etzer Darout initiates coverage on Celldex Therapeutics (NASDAQ:CLDX) with a Underweight rating and announc...

5-analysts-assess-celldex-therapeutics-what-you-need-to-know
5 Analysts Assess Celldex Therapeutics: Wh...
09/17/2025 14:01:35

canaccord-genuity-maintains-buy-on-celldex-therapeutics-maintains-62-price-target
Canaccord Genuity Maintains Buy on Celldex...
09/17/2025 13:35:57

Canaccord Genuity analyst Edward Nash maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and maintains $62 price target.

celldex-presents-phase-2-data-showing-barzolvolimab-improves-chronic-spontaneous-urticaria-independent-of-baseline-immunoglobulin-e-levels-at-eadv-2025
Celldex Presents Phase 2 Data Showing Barz...
09/17/2025 09:14:33

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/08/2025 21:07:27

wells-fargo-maintains-overweight-on-celldex-therapeutics-lowers-price-target-to-38
Wells Fargo Maintains Overweight on Cellde...
08/20/2025 18:47:53

Wells Fargo analyst Derek Archila maintains Celldex Therapeutics (NASDAQ:CLDX) with a Overweight and lowers the price target...

citigroup-maintains-buy-on-celldex-therapeutics-lowers-price-target-to-48
Citigroup Maintains Buy on Celldex Therape...
08/20/2025 16:06:40

Citigroup analyst David Lebowitz maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and lowers the price target from $5...

celldex-therapeutics-pulls-plug-on-eosinophilic-esophagitis-investigational-drug-as-data-falls-short
Celldex Therapeutics Pulls Plug On Eosinop...
08/20/2025 14:22:16

Celldex will stop developing barzolvolimab in eosinophilic esophagitis after Phase 2 data showed strong mast cell reduction but...

what-analysts-are-saying-about-celldex-therapeutics-stock
What Analysts Are Saying About Celldex The...
08/20/2025 14:01:48

canaccord-genuity-maintains-buy-on-celldex-therapeutics-lowers-price-target-to-62
Canaccord Genuity Maintains Buy on Celldex...
08/20/2025 13:54:53

Canaccord Genuity analyst Edward Nash maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and lowers the price target fr...

la-z-boy-posts-downbeat-q1-results-joins-james-hardie-industries-alcon-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
La-Z-Boy Posts Downbeat Q1 Results, Joins ...
08/20/2025 12:27:54

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/20/2025 12:08:41

why-rocket-pharmaceuticals-shares-are-trading-higher-by-over-15-here-are-20-stocks-moving-premarket
Why Rocket Pharmaceuticals Shares Are Trad...
08/20/2025 11:24:03

hc-wainwright--co-maintains-buy-on-celldex-therapeutics-lowers-price-target-to-42
HC Wainwright & Co. Maintains Buy on Celld...
08/20/2025 10:42:56

HC Wainwright & Co. analyst Joseph Pantginis maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and lowers the pric...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 21:06:03

celldex-reports-phase-2-topline-results-for-barzolvolimab-in-eosinophilic-esophagitis-says-study-met-primary-endpoint-demonstrating-barzolvolimabs-ability-to-potently-deplete-mast-cells-in-gastrointestinal-tract
Celldex Reports Phase 2 Topline Results Fo...
08/19/2025 20:03:35

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported topline results from the Company's ongoing Phase 2 study of barzolv...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION